Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation - PubMed (original) (raw)

Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation

I P Oswald et al. Proc Natl Acad Sci U S A. 1992.

Abstract

Interleukin 10 (IL-10) inhibits interferon gamma-induced macrophage activation for cytotoxicity against larvae of the human parasite Schistosoma mansoni by suppressing production of the toxic effector molecule nitric oxide (NO). In this study, the mechanism of IL-10 action was identified as inhibition of endogenous tumor necrosis factor alpha (TNF-alpha) production by interferon gamma-activated macrophages. TNF-alpha appears to serve as a cofactor for interferon gamma-mediated activation, since both schistosomulum killing and NO production were inhibited by anti-TNF-alpha antibody, whereas TNF-alpha alone was unable to stimulate these macrophage functions. IL-10 blocked TNF-alpha production by interferon gamma-treated macrophages at the levels of both protein and mRNA synthesis. Addition of exogenous TNF-alpha reversed IL-10-mediated suppression of macrophage cytotoxic activity as well as NO production. Likewise, addition of a macrophage-triggering agent (bacterial lipopolysaccharide or muramyl dipeptide), which induced the production of TNF-alpha, also reversed the suppressive effect of IL-10 on cytotoxic function. In contrast to IL-10, two other cytokines, IL-4 and transforming growth factor beta, which also inhibit macrophage activation for schistosomulum killing and NO production, did not substantially suppress endogenous TNF-alpha production. These results, therefore, describe a separate pathway by which macrophage microbicidal function is inhibited by the down-regulatory cytokine IL-10.

PubMed Disclaimer

Cited by

Screening and identification of the core immune-related genes and immune cell infiltration in severe burns and sepsis.
Su W, Li W, Zhang Y, Wang K, Chen M, Chen X, Li D, Zhang P, Yu D. Su W, et al. J Cell Mol Med. 2023 Jun;27(11):1493-1508. doi: 10.1111/jcmm.17749. Epub 2023 Apr 15. J Cell Mol Med. 2023. PMID: 37060578 Free PMC article.
Unwinding the mechanism of macrophage repolarization potential of Oceanimonas sp. _BPMS22_-derived protein protease inhibitor through Toll-like receptor 4 against experimental visceral leishmaniasis.
Jayaraman A, Srinivasan S, Uppuluri KB, Kar Mahapatra S. Jayaraman A, et al. Front Cell Infect Microbiol. 2023 Mar 22;13:1120888. doi: 10.3389/fcimb.2023.1120888. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37033485 Free PMC article.
Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC.
Madduri BTSA, Allen L, Taylor SC, Besra GS, Alderwick LJ. Madduri BTSA, et al. Cell Surf. 2022 Nov 11;8:100088. doi: 10.1016/j.tcsw.2022.100088. eCollection 2022 Dec. Cell Surf. 2022. PMID: 36405350 Free PMC article.
Genetic and immune crosstalk between severe burns and blunt trauma: A study of transcriptomic data.
Chen X, Wang K, Li D, Zhao M, Huang B, Su W, Yu D. Chen X, et al. Front Genet. 2022 Sep 30;13:1038222. doi: 10.3389/fgene.2022.1038222. eCollection 2022. Front Genet. 2022. PMID: 36246590 Free PMC article.
Early detection of soluble CD27, BTLA, and TIM-3 predicts the development of nosocomial infection in pediatric burn patients.
Penatzer JA, Alexander R, Simon S, Wolfe A, Breuer J, Hensley J, Fabia R, Hall M, Thakkar RK. Penatzer JA, et al. Front Immunol. 2022 Jul 26;13:940835. doi: 10.3389/fimmu.2022.940835. eCollection 2022. Front Immunol. 2022. PMID: 35958579 Free PMC article.

References

1. Methods Enzymol. 1986;132:649-58 - PubMed
1. Immunol Rev. 1987 Jun;97:5-27 - PubMed
1. Biochem Biophys Res Commun. 1988 Nov 30;157(1):87-94 - PubMed
1. Eur J Immunol. 1988 Oct;18(10):1587-92 - PubMed
1. Immunol Rev. 1992 Jun;127:183-204 - PubMed

Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation - PubMed (original) (raw)